EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)
| 10.53 Delayed Data As of 3:59pm ET |  -0.51 / -4.62%Today’s Change | 3.51 Today|||52-Week Range 15.06 | +60.03% Year-to-Date |
Latest EYPT News | Press Releases
| 4 Stocks to Keep a Watch on Amid Growing Optical Care Demand Sep 07 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 11.04 |
| Today’s open | 10.03 |
| Day’s range | 9.34 - 11.12 |
| Volume | 4,835 |
| Average volume (3 months) | 156,939 |
| Market cap | $320.5M |
Data as of 3:59pm ET, 09/20/2021
Growth & Valuation
| Earnings growth (last year) | +35.05% |
| Earnings growth (this year) | +54.12% |
| Earnings growth (next 5 years) | +11.80% |
| Revenue growth (last year) | +69.10% |
| P/E ratio | NM |
| Price/Sales | 2.45 |
| Price/Book | 10.90 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FLXNFlexion Therapeutics... | -0.12 | -1.93% |
| INFIInfinity Pharmaceuti... | -0.25 | -6.75% |
| VIRXViracta Therapeutics... | -0.33 | -3.79% |
| CTXRCitius Pharmaceutica... | -0.09 | -4.57% |
Data as of 4:00pm ET, 09/20/2021
Financials
| Next reporting date | November 4, 2021 |
| EPS forecast (this quarter) | -$0.40 |
| Annual revenue (last year) | $34.4M |
| Annual profit (last year) | -$45.4M |
| Net profit margin | -131.82% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Watertown, Massachusetts |
Forecasts
